Lansoprazole triple therapy for Turkish children with Helicobacter pylori infections.
Koçak
N
N
Saltik
I N
IN
Ozen
H
H
Yüce
A
A
Gürakan
F
F
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000293:Adolescent; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D009853:Omeprazole / Q000031:analogs & derivatives / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D064747:Lansoprazole; D009853:Omeprazole